An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine. The company said the newly approved formulation ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

The global outbreak of mpox in 2022–23 affected more than 100 countries and grabbed the attention of the scientific community ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

The JYNNEOS vaccine protects against both mpox and smallpox, and is a two-dose vaccine given four weeks apart. Full protection is achieved two weeks after the second dose. If you are traveling to ...

China on Thursday reported an outbreak of monkeypox virus, specifically the Ib sub-branch, with four associated cases. The ...

Health officials are advising people at higher risk of mpox infection to consider being vaccinated with two doses of the JYNNEOS vaccine, which is available statewide. Laboratory testing of the ...

Discover why BVNKF's vaccine innovations, growth catalysts, and compelling valuation after a 52% pullback make it a strong ...

The freeze-dried formulation provides flexibility with regard to storage and shelf life. The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox ...

Marketed as Jynneos in the US, the vaccine currently exists in a liquid-frozen formulation. These products require a temperature-controlled supply chain that keeps them frozen between production ...

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...